Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

azenta inc. - AZTA

AZTA

Close Chg Chg %
35.60 -0.50 -1.40%

Closed Market

35.10

-0.50 (1.40%)

Volume: 718.17K

Last Updated:

Dec 4, 2025, 4:00 PM EDT

Trade Now

Company Overview: azenta inc. - AZTA

AZTA Key Data

Open

$35.49

 Day Range

34.72 - 35.86

52 Week Range

23.98 - 55.64

 Market Cap

$1.63B

Shares Outstanding

45.84M

 Public Float

44.65M

Beta

1.29

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$1.30

Yield

0.00%

 Dividend

$0.10

EX-DIVIDEND DATE

Dec 2, 2021

 SHORT INTEREST

N/A

AVERAGE VOLUME

644.56K

  

AZTA Performance

1 Week
 
 0.11%
 
1 Month
 
 21.21%
 
3 Months
 
 17.49%
 
1 Year
 
 -21.91%
 
5 Years
 
 -52.65%
 

AZTA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About azenta inc. - AZTA

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

AZTA At a Glance

Azenta, Inc.
200 Summit Drive
Burlington, Massachusetts 01803
Phone 1-978-262-2400 Revenue 593.82M
Industry Medical/Nursing Services Net Income -59,503,000.00
Sector Health Services Employees N/A
Fiscal Year-end 09 / 2026
View SEC Filings

AZTA Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.212
Price to Book Ratio 0.764
Price to Cash Flow Ratio 18.20
Enterprise Value to EBITDA 29.359
Enterprise Value to Sales 1.721
Total Debt to Enterprise Value 0.05

AZTA Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 3.909
Total Asset Turnover 0.286

AZTA Liquidity

Current Ratio 2.957
Quick Ratio 2.645
Cash Ratio 1.431

AZTA Profitability

Gross Margin 45.515
Operating Margin -3.65
Pretax Margin -1.203
Net Margin -10.02
Return on Assets 1.138
Return on Equity 1.355
Return on Total Capital 1.333
Return on Invested Capital 1.313

AZTA Capital Structure

Total Debt to Total Equity 2.974
Total Debt to Total Capital 2.888
Total Debt to Total Assets 2.491
Long-Term Debt to Equity 2.974
Long-Term Debt to Total Capital 2.888
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Azenta Inc. - AZTA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
555.50M 665.07M 656.32M 593.82M
Sales Growth
+8.14% +19.73% -1.32% -9.52%
Cost of Goods Sold (COGS) incl D&A
324.88M 431.82M 419.46M 323.54M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
53.70M 85.58M 90.74M 56.47M
Depreciation
21.41M 37.21M 39.47M 32.03M
Amortization of Intangibles
32.29M 48.38M 51.27M 24.44M
COGS Growth
+8.59% +32.92% -2.86% -22.87%
Gross Income
230.62M 233.26M 236.87M 270.28M
Gross Income Growth
+7.51% +1.14% +1.55% +14.11%
Gross Profit Margin
+41.52% +35.07% +36.09% +45.52%
2022 2023 2024 2025 5-year trend
SG&A Expense
254.64M 315.45M 309.76M 291.95M
Research & Development
27.54M 33.96M 33.52M 30.39M
Other SG&A
227.10M 281.50M 276.24M 261.56M
SGA Growth
+20.73% +23.88% -1.80% -5.75%
Other Operating Expense
- - - -
-
Unusual Expense
1.34M (9.07M) 127.78M 5.17M
EBIT after Unusual Expense
(25.37M) (73.13M) (200.68M) (26.84M)
Non Operating Income/Expense
20.02M 42.69M 33.35M 19.70M
Non-Operating Interest Income
20.29M 43.73M 33.18M 18.78M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 4.59M
-
Interest Expense Growth
- - - +125.28%
-
Gross Interest Expense
- - - 4.59M
-
Interest Capitalized
- - - -
-
Pretax Income
(9.94M) (30.43M) (167.32M) (7.14M)
Pretax Income Growth
+79.71% -206.29% -449.81% +95.73%
Pretax Margin
-1.79% -4.58% -25.49% -1.20%
Income Tax
1.35M (17.55M) (3.15M) (30.80M)
Income Tax - Current - Domestic
- (4.22M) 929.00K 1.71M
Income Tax - Current - Foreign
- 4.63M 9.76M 11.22M
Income Tax - Deferred - Domestic
- (995.00K) (19.09M) (5.14M)
Income Tax - Deferred - Foreign
- 1.94M (9.15M) (10.94M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(11.29M) (12.88M) (164.17M) 23.66M
Minority Interest Expense
- - - -
-
Net Income
(11.29M) (12.88M) (164.17M) 23.66M
Net Income Growth
+60.91% -14.15% -1,174.31% +114.41%
Net Margin Growth
-2.03% -1.94% -25.01% +3.98%
Extraordinaries & Discontinued Operations
- (417.68M) (1.37M) (83.16M)
Discontinued Operations
- (417.68M) (1.37M) (83.16M)
Net Income After Extraordinaries
(428.96M) (14.26M) (164.17M) (59.50M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(428.96M) (14.26M) (164.17M) (59.50M)
EPS (Basic)
-5.7274 -0.2152 -3.0873 -1.3008
EPS (Basic) Growth
-483.87% +96.24% -1,334.62% +57.87%
Basic Shares Outstanding
74.90M 66.25M 53.17M 45.74M
EPS (Diluted)
-5.7274 -0.2152 -3.0873 -1.3008
EPS (Diluted) Growth
-485.06% +96.24% -1,334.62% +57.87%
Diluted Shares Outstanding
74.90M 66.25M 53.17M 45.74M
EBITDA
29.68M 3.39M 17.85M 34.80M
EBITDA Growth
-50.92% -88.59% +427.14% +94.97%
EBITDA Margin
+5.34% +0.51% +2.72% +5.86%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 35.571
Number of Ratings 8 Current Quarters Estimate 0.136
FY Report Date 12 / 2025 Current Year's Estimate 0.781
Last Quarter’s Earnings 0.21 Median PE on CY Estimate N/A
Year Ago Earnings 0.51 Next Fiscal Year Estimate 0.996
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 8 8
Mean Estimate 0.14 0.15 0.78 1.00
High Estimates 0.18 0.17 0.81 1.09
Low Estimate 0.11 0.13 0.75 0.86
Coefficient of Variance 20.78 8.20 2.86 7.39

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 1
OVERWEIGHT 1 1 1
HOLD 5 5 5
UNDERWEIGHT 0 0 0
SELL 0 0 1
MEAN Overweight Overweight Hold

Insider Actions for Azenta Inc. - AZTA

Date Name Shares Transaction Value
Aug 13, 2025 Lawrence Lin EVP, CFO and Treasurer 46,013 Open market or private purchase of non-derivative security Non-derivative transaction at $27.96 per share 1,286,523.48
May 21, 2025 William Lindsay Cornog Director 14,855 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $26.5 per share 393,657.50
May 21, 2025 William Lindsay Cornog Director 19,007 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $26.98 per share 512,808.86
May 21, 2025 William Lindsay Cornog Director 21,755 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $27.37 per share 595,434.35

Azenta Inc. in the News